UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No.   )*

 

 

 

 

GEOVAX LABS, INC.

 

 

 

  

 

 

 

(Name of Issuer)

 

 

 

 

 

Common stock, $0.001 par value per share

 

 

 

  

 

 

 

(Title of Class of Securities)

 

 

 

 

 

373678101

 

 

 

  

 

 

 

(CUSIP Number)

 

 

 

 

 

9/29/2009

 

 

 

  

 

 

 

(Date of Event which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

o Rule 13d-1 (b)
x Rule 13d-1 (c)
o Rule 13d-1 (d)

 

 
 

 
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


 

CUSIP No. 373678101

 
 

 

(1) Names and I.R.S. Identification Nos.(entities only) of reporting persons.

 

Papageorgiou, Stavros

 
 

 

(2) Check the appropriate box if a member of a group (see instructions)

(a) o

(b) o

 
 

 

(3) SEC use only.

 
 

 

(4) Citizenship or place of organization.

 

Citizen of Greece

 
 

 

Number of shares beneficially owned by each reporting person with:

(5) Sole voting power:

 

30,400,903

 

(6) Shared voting power:

 

25,192,013

 

(7) Sole dispositive power:

 

30,400,903

 

(8) Shared dispositive power:

 

25,192,013

 
 

 

(9) Aggregate amount beneficially owned by each reporting person.

 

55,592,916

 
 

 

(10) Check if the aggregate amount in Row (9) excludes certain shares o

(see instructions).

 
 

 

(11) Percent of class represented by amount in Row 9.

 

7.1040%

 
 

 

(12) Type of reporting person (see instructions).

 

IN

 
 

2

Item 1(a). Name of Issuer:
GeoVax Labs, Inc.

Item 1(b). Address of Issuer’s Principal Executive Offices:
1256 Briarcliff Road, N.E. Emtech Bio, Suite 500, Atlanta, Georgia 30306

Item 2(a). Name of Person Filing:
Papageorgiou, Stavros

Item 2(b). Address or Principal Business Office or, If None, Residence:
c/o Morse, Zelnick, Rose & Lander LLP, 405 Park Avenue, Suite 1401, New York, New York 10022

Item 2(c). Citizenship:
Citizen of Greece

Item 2(d). Title of Class of Securities:
Common stock, $0.001 par value per share

Item 2(e). CUSIP No.:
373678101

Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:

 

(a) o Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

(b) o Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

(c) o Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

(d) o Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8).

(e) o An investment adviser in accordance with ss. 240.13d-1(b)(1)(ii)(E);

(f) o An employee benefit plan or endowment fund in accordance with ss.240.13d-1(b)(1)(ii)(F);

(g) o A parent holding company or control person in accordance with ss.240.13d- 1(b)(1)(ii)(G);

(h) o A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i) o A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j) o A non-U.S. institution in accordance with ss. 240.13d-1(b)(1)(ii)(J);

(k) o Group, in accordance with ss. 240.13d-1(b)(1)(ii)(K).

If this statement is filed pursuant to Rule 13d-1(c), check this box. x

Item 4. Ownership
(a) Amount beneficially owned: 55,592,9161

(b) Percent of class: 7.1040%

 

 
 

 

1 Includes 4,592,742 shares underlying immediately exercisable outstanding warrants.

3

(c) Number of shares as to which such person has:

          (i) Sole power to direct the vote: 30,400,903

          (ii) Shared power to direct the vote: 25,192,013

          (iii) Sole power to dispose or direct the disposition of: 30,400,903

          (iv) Shared power to dispose or direct the disposition of: 25,192,013

Item 5. Ownership of 5 Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following o

Item 6. Ownership of More than 5 Percent on Behalf of Another Person.

Not Applicable.

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

Not Applicable.

Item 8. Identification and Classification of Members of the Group.

Not Applicable.

Item 9. Notice of Dissolution of Group.

Not Applicable.

4

Item 10. Certifications

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

 

 

Date: 9/29/2009

/s/Stavros Papageorgiou

 

 

  

 

 

Name: Stavros Papageorgiou

The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement, Provided, however, That a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

ATTENTION: Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001). (Secs. 3(b), 13(d)(1), 13(d)(2), 13(d)(5), 13(d)(6), 13(g)(1), 13(g)(2), 13(g)(5), 23, 48 Stat. 882, 894, 901; sec. 203(a), 49 Stat. 704; sec. 8, 49 Stat. 1379; sec. 10, 78 Stat. 88a; sec. 2, 82 Stat. 454; secs. 1, 2, 84 Stat. 1497; secs. 3, 10, 18, 89 Stat. 97, 119, 155; secs. 202, 203, 91 Stat. 1494, 1498, 1499; (15 U.S.C. 78c(b), 78m(d)(1), 78m(d)(2), 78m(d)(5), 78m(d)(6), 78m(g)(1), 78m(g)(2), 78m(g)(5), 78w)) [43 FR 18499, Apr. 28, 1978, as amended at 43 FR 55756, Nov. 29, 1978; 44 FR 2148, Jan. 9, 1979; 44 FR 11751, Mar. 2, 1979; 61 FR 49959, Sept. 24, 1996; 62 FR35340, July 1, 1997; 63 FR 2867, Jan. 16, 1998; 63 FR 15287, Mar. 31, 1998]

5